İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

Analysis of dux4 expression in bone marrow and re-discussion of dux4 function in the health and disease

Dergi Turkish Journal of Pathology ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN1018-5615
YÖKSİS OpenAlex Açık erişim · diamond
Yıl2022
Atıf1OpenAlex
Yüzdelik%15,1
FWCI0,01,00 = dünya ortalaması
Scopus (SJR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTurkish Journal of Pathology
  • Katalog eşleşmesi (ISSN)Turk Patoloji Dergisi
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVE: DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question "Could DUX4 be a TF that is active in certain types of potent somatic cells?" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow. MATERIAL AND METHOD: Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material. RESULTS: DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry. CONCLUSION: With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

1atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 3 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophyAtıf 2 · OpenAlex
  2. 2025 Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophyAtıf 2 · OpenAlex
  3. 2025 Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophyAtıf 2 · OpenAlex

Yazarlar

7
  1. CEREN HANGÜL MADEN AKDENİZ ÜNİVERSİTESİ 1
  2. Öznur TOKTA 2
  3. SİBEL KARAÜZÜM 3
  4. BAHAR AKKAYA 4
  5. Hülya YILDIRIM 5
  6. FUNDA TAYFUN KÜPESİZ 6
  7. AYŞE NUR AKINEL 7